Crossmark

Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations

Crossref DOI link: https://doi.org/10.1007/s13300-017-0328-6

Published Online: 2017-11-07

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deed, Gary

Kilov, Gary

Dunning, Trisha

Cutfield, Richard

Overland, Jane

Wu, Ted
Funding

Funding for this research was provided by:

Eli Lilly and Company
License Information

Text and Data Mining valid from 2017-11-07
More Information

Article History

Received: 22 August 2017

First Online: 7 November 2017